Genome BC Invests in Anandia Labs — a Leader in Cannabis Biotechnology and Safety

VANCOUVER, BC–(Marketwired – September 27, 2016) – Genome BC is pleased to announce that it has made its first investment through its Industry Innovation (I²) Program to Anandia Laboratories Inc. (Anandia Labs). Anandia Labs is a Vancouver-based cannabis biotechnology company with two objectives: providing leading analytical testing services to the regulated cannabis industry in Canada; and developing improved cannabis and hemp strains for novel, safe, and effective medical applications. According to Health Canada, close to 70,000 Canadians…